By Monica Heger
As exome sequencing quickly becomes the method of choice for diagnosing rare conditions, a number of academic groups and companies have launched tests in recent months and are reporting their first successes.
Ambry Genetics is now offering sequencing services on Illumina's MiSeq instrument. It offers both single- and paired-end sequencing with 50-base pair or 100-base pair reads, as well as indexing and barcoding.
By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Ambry Genetics will use Agilent Technologies' SureSelect Target Enrichment System for the exome sequencing services it provides for its customers, the firms announced today.